LONDON : Imperial College London is setting up a new enterprise to distribute a potential Covid-19 vaccine at a lower price.The British university, together with partner Morningside Ventures, will waive royalties and charge only “modest cost-plus prices" to sustain the enterprise’s work, according to a statement on Sunday.
The enterprise will be called VacEquity Global Health.Another company, VaXEquity, is also being launched to accelerate the manufacturing scale of the vaccine.“These new enterprises are the most effective way for us to deliver Covid-19 vaccines quickly, cheaply and internationally, while preparing for future pandemics," said Professor Robin Shattock, head of mucosal infection and immunity at Imperial and co-founder of the.